Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

AVEN Antikörper (AA 301-362) (Alexa Fluor 555)

AVEN Reaktivität: Human WB, IF (cc), IF (p) Wirt: Kaninchen Polyclonal Alexa Fluor 555
Produktnummer ABIN884254
  • Target Alle AVEN Antikörper anzeigen
    AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
    Bindungsspezifität
    • 14
    • 13
    • 8
    • 6
    • 1
    • 1
    • 1
    • 1
    AA 301-362
    Reaktivität
    • 48
    • 13
    • 6
    • 3
    Human
    Wirt
    • 45
    • 3
    Kaninchen
    Klonalität
    • 44
    • 3
    Polyklonal
    Konjugat
    • 18
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser AVEN Antikörper ist konjugiert mit Alexa Fluor 555
    Applikation
    • 40
    • 22
    • 12
    • 12
    • 7
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
    Homologie
    Human,Mouse,Rat,Pig,Horse,Chicken,Rabbit
    Aufreinigung
    Purified by Protein A.
    Immunogen
    KLH conjugated synthetic peptide derived from human AVEN
    Isotyp
    IgG
    Top Product
    Discover our top product AVEN Primärantikörper
  • Applikationshinweise
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
    Haltbarkeit
    12 months
  • Target
    AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
    Andere Bezeichnung
    Aven (AVEN Produkte)
    Synonyme
    AVEN antikoerper, pdcd12 antikoerper, aven antikoerper, wu:fc08c09 antikoerper, si:ch211-150c22.4 antikoerper, PDCD12 antikoerper, 1700013A01Rik antikoerper, 1700056A21Rik antikoerper, mAven-L antikoerper, mAven-S antikoerper, apoptosis and caspase activation inhibitor antikoerper, apoptosis, caspase activation inhibitor L homeolog antikoerper, apoptosis, caspase activation inhibitor antikoerper, Aven antikoerper, AVEN antikoerper, aven.L antikoerper, aven antikoerper
    Hintergrund

    Synonyms: 1700013A01Rik, 1700056A21Rik, mAven L, mAven S, MGC124011, Apoptosis caspase activation inhibitor, Cell death regulator Aven, OTTMUSP00000016129, PDCD12, Programmed cell death 12, RP23-52C15.2, AVEN_HUMAN

    Background: Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Disruption of this process has been implicated in a variety of diseases such as cancer. AVEN is a recently discovered protein that blocks apoptosis induced by Apaf-1 and caspase-9. It is thought that AVEN functions by binding to Bcl-xL, an antiapoptotic member of the Bcl-2 family, and to Apaf-1, possibly interfering with the ability of Apaf-1 to self-associate, suggesting that AVEN impedes Apaf-1-mediated caspase activation. Higher levels of AVEN mRNA are seen in patients with acute leukemia than in control patients, suggesting that AVEN may be useful as a prognostic indicator in leukemia patients.

    Gen-ID
    57099
Sie sind hier:
Kundenservice